On the stock market since 2010, it operates in the everyday-essentials business. It has 130,000 employees. Now — the numbers.
This is an established company with proven profits.
No real growth (1% a year).
The gap is $7.6B. In times of high interest rates, a gap like that can squeeze a company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
The stock trades below its recent peak — about 14% off the top. A pullback, not a collapse.
The average analyst price target is $58.00 — 61% above today’s price.
It pays out $0.65 per share each year — regular cash for whoever holds the stock.
Over the last 3 years, sales grew only 2% a year on average. At this size, speeding back up is not easy.
The company’s market value is 41 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, EMLAF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: EMLAF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.